Rock Springs Capital Management LP Bristol Myers Squibb CO Transaction History

Rock Springs Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $6.96 Million - $10.1 Million	-150,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $7.38 Million - $9.63 Million	150,000 New	150,000 $9.63 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $44.9 Million - $53.2 Million	-1,050,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $46.9 Million - $51.8 Million	1,050,000 New	1,050,000 $47.6 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $32.8 Million - $40.9 Million	-650,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $36 Million - $41.4 Million	600,000 Added 1200.0%	650,000 $41.1 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $2.76 Million - $3.19 Million	50,000	50,000 $3.19 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.